Ikonisys S.A. (EPA:ALIKO)
France
· Delayed Price · Currency is EUR 1.520
-0.020 (-1.30%)
Mar 9, 2026, 5:27 PM CET
Ikonisys Revenue
Ikonisys had revenue of 761.02K EUR in the half year ending June 30, 2025, with 490.35% growth. This brings the company's revenue in the last twelve months to 1.47M, up 81.20% year-over-year. In the year 2024, Ikonisys had annual revenue of 1.01M with 56.72% growth.
Revenue (ttm)
1.47M
Revenue Growth
+81.20%
P/S Ratio
16.55
Revenue / Employee
98.31K
Employees
15
Market Cap
24.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.01M | 365.94K | 56.72% |
| Dec 31, 2023 | 645.17K | 28.31K | 4.59% |
| Dec 31, 2022 | 616.87K | 74.17K | 13.67% |
| Dec 31, 2021 | 542.70K | 57.53K | 11.86% |
| Dec 31, 2020 | 485.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Theraclion | 1.87M |
| Novacyt | 22.69M |
| Implanet | 11.10M |
| Diagnostic Medical Systems | 49.47M |
| Mauna Kea Technologies | 8.18M |
| Biosynex | 97.95M |
| SpineGuard | 4.32M |
| Bluelinea Société Anonyme | 11.68M |